Protective effect of whey proteins against nonalcoholic fatty liver in rats

Table 3 Effect of oral administration of whey proteins products on malondialdehyde and reduced glutathione in rats fed the normal and high carbohydrate, fat free diets

	Malondialdehyde (nmol/g liver)	Reduced Glutathione ( mg/g liver)
Control	220.33 ± 3.65^b	91.58 ± 7.33^ab
HCFFD	549.48 ± 7.99^a	69.57 ± 8.37^b
WPI	280.37 ± 1.42^b	117.42 ± 5.50^a
WPH	230.36 ± 7.45^b	125.78 ± 3.56^a
αLA	227.31 ± 6.12^b	110.82 ± 4.92^ab
βLG	229.99 ± 2.81^b	115.27 ± 1.91^a
GMP	365.56 ± 9.40^ab	109.49 ± 2.70^ab

Mean values with their standard deviation for five rats per group
WPI: whey protein isolate, WPH: whey protein hydrolysate, αLA: alpha lactalbumin, βLG: Beta lactoglobulin, GMP: glycomacropeptide.
Means in a column without common letter significantly differ, P < 0.05 (Tukey's test).

ISSN: 1476-511X